Stock Price
1.31
Daily Change
0.09 7.38%
Monthly
14.91%
Yearly
-11.49%
Q2 Forecast
1.19

Actinium Pharmaceuticals reported $90K in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AbbVie USD 15B 1.62B Mar/2026
Actinium Pharmaceuticals USD 90K 9K Sep/2025
Amgen USD 8.62B 1.28B Mar/2026
Bioline Rx USD 427K 123K Sep/2025
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Pfizer USD 14.5B 3.08B Mar/2026